An interventional study of Whole-Body Electromyostimulation Training in Physical Activity, sponsored by Universidad de Granada. Completed at 1 site in Spain. Open to male participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-08.
Sponsored by Universidad de Granada · Not applicable, Interventional, and Other
Among 31 studies in Motor Activity by Universidad de Granada — 5 open to participants now, 6 under way, none of them phase 3. Motor Activity · Universidad de Granada.
Among the 31 studies in Motor Activity by Universidad de Granada, this one is the 29th largest by enrollment of the 30 interventional ones that give a count, is one of 2 that started in 2017, is one of 28 with no phase, and was the 12th registered.
9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.
Browse Motor Activity studies →5 of the 31 studies in Motor Activity by Universidad de Granada are open now, in 1 country. Recruiting first, the newest first:
Universidad de Granada · Sites in Spain
Universidad de Granada · Sites in Spain
Universidad de Granada · Sites in Spain
Universidad de Granada · Sites in Spain
Universidad de Granada · Sites in Spain
By country, each count listing its studies:
Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 1
First in 2011; this study’s year is marked. 2 started in 2017.
This study's enrollment of 14 is below the median of 60 across 8,388 interventional studies indexed under Motor Activity.
Median enrollment 99 across the 30 interventional studies, 35,000 across the 1 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Universidad de Granada is the lead sponsor of 246 studies on the registry; 43 are open to participants now.
2 of the studies in Motor Activity by Universidad de Granada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06518200Universidad de GranadaPreventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support | 2026-12-30 |
| NCT07022262Universidad de GranadaVirtual Exercise Training and Its Impact on Bone Compartments in Adult Survivors of Childhood Cancer | 2027-08 |
Among the 31 studies in Motor Activity by Universidad de Granada, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The subjects will be randomly distributed into 3 experimental groups: training with basic global electrostimulation (WB-EMS-SRT), training with specific global electrostimulation for runners (WB-EMS-WT) and control group (CG).
Initially and at the end of the intervention period, which will consist of six weeks, the subjects will undergo a series of tests: (1) Maximum incremental effort test in tapestry to exhaustion to determine cardiorespiratory capacity (VO2max) and thresholds (aerobic and anaerobic). (2) Submaximal carpet test at constant speed to determine race economy (EC). (3) Lower train power test (CMJ and Abalakov). (4) Weight, size and waist circumference. The aforementioned tests will be carried out on different days to avoid the effect of fatigue on performance with a break of more than 48 hours between tests.
The participants in the control group will maintain the volume and intensity of the training prior to the intervention study and the subjects of the WB-EMS and WB-EMS-AC groups will substitute one conventional training day for one with global electrostimulation for six weeks; the training of the first group will be non-specific and that of the second specific for runners and the duration of both will be 20 minutes.
A randomized controlled trial design was applied following CONSORT statements. After baseline measurements, participants were randomized into two groups: (i) WB-EMS group and (ii) Control Group (CG). Participants in the WB-EMS group were instructed to reduce their running training program volume, whereas the CG continued with their running training in term of volume and intensity: two or three times per week (45-60 minutes per day) at an intensity of 60-70% hearth rate reserve, which was controlled by heart rate monitor (Polar RS300X, POLAR, Kempele, Finland), and with 24-48 hours of rest between sessions
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Training with basic global electrostimulation
Other: Whole-Body Electromyostimulation Training
Training with specific global electrostimulation for runners
Other: Whole-Body Electromyostimulation Training
The participants in the control group will maintain the volume and intensity of the training prior to the intervention study and the subjects of the WB-EMS and WB-EMS-AC groups will substitute one conventional training day for one with global electrostimulation for six weeks; the training of the first group will be non-specific and that of the second specific for runners and the duration of both will be 20 minutes.
Other: Whole-Body Electromyostimulation Training
The WB-EMS training program consisted of six WB-EMS training sessions (one per week) and six running training sessions (also one per week). This intervention programme followed a within-day undulating periodization model. The training sessions were divided into four parts: warm up (A), strength (B), high intensity interval power training (c), and high intensity interval training (HIIT) (D).
Maximal oxygen consumption
Maximal Oxygen consumption was assessed using a maximum treadmill (H/P/ Cosmos Pulsar treadmill, H/P/Cosmos Sport \& Medical GMBH, Germany) exercise test with a progressive incremental protocol that has been used.
Time frame: Baseline and through study completion, an average of 5 weeks
Ventilatory thresholds
VT1 and VT2 were estimated from gas exchange data through different respiratory variables: minute ventilation (VE) and equivalents for oxygen (VE/VO2) and carbon dioxide (VE/VCO2) by two independent researchers
Time frame: Baseline and through study completion, an average of 5 weeks
Running economy
RE was determined during a treadmill test following a specific protocol used in previous studies
Time frame: Baseline and through study completion, an average of 5 weeks
Muscular power
Vertical jump performance was assessed using the Bosco Test.
Time frame: Baseline and through study completion, an average of 5 weeks
Weight
Weight in Kilograms
Time frame: Baseline and through study completion, an average of 5 weeks
Body composition
Assessed using DXA.
Time frame: Baseline and through study completion, an average of 5 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Dec 2017 to primary completion in Dec 2017, 0 months.
Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 0 months is below that.
Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.